References
- Ingulli E, Mondino A, Khoruts A, et al. In vivo detection of dendritic cell antigen presentation to CD4(+) T cells. J Exp Med. 1997;185(12):2133–2141.
- Sim WJ, Ahl PJ, Connolly JE. Metabolism is central to tolerogenic dendritic cell function. Mediators Inflamm. 2016;2016:1.
- Lu H, Yao K, Huang D, et al. High glucose induces upregulation of scavenger receptors and promotes maturation of dendritic cells. Cardiovasc Diabetol. 2013;12(1):80.
- Lawless SJ, Kedia-Mehta N, Walls JF, et al. Glucose represses dendritic cell-induced T cell responses. Nat Commun. 2017;8(1):15620.
- Feng M, Li J, Wang J, et al. High glucose increases LPS-induced DC apoptosis through modulation of ERK1/2, AKT and Bax/Bcl-2. BMC Gastroenterol. 2014;14(1):98.
- Levine AJ, Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science. 2010;330(6009):1340–1344.
- Luo Y, Lei M. α-Mangostin protects against high-glucose induced apoptosis of human umbilical vein endothelial cells. Biosci Rep. 2017;37:1–10.
- Ohtsuka S, Murao K, Imachi H, et al. Prolactin regulatory element binding protein as a potential transcriptional factor for the insulin gene in response to glucose stimulation. Diabetologia. 2006;49(7):1599–1607.
- Liu E, Law HK, Lau YL. Insulin-like growth factor I promotes maturation and inhibits apoptosis of immature cord blood monocyte-derived dendritic cells through MEK and PI 3-kinase pathways. Pediatr Res. 2003;54(6):919–925.
- Xuan NT, Hoang NH, Nhung VP, et al. Regulation of dendritic cell function by insulin/IGF-1/PI3K/Akt signaling through klotho expression. J Recept Signal Transduct Res. 2017;37(3):297–303.
- Djiogue S, Nwabo Kamdje AH, Vecchio L, et al. Insulin resistance and cancer: the role of insulin and IGFs. Endocr Relat Cancer. 2013;20(1):R1–R17.
- Matheny RW, Jr., Geddis AV, Abdalla MN, et al. AKT2 is the predominant AKT isoform expressed in human skeletal muscle. Physiol Rep. 2018;6(6):e13652.
- Kempe DS, Siraskar G, Frohlich H, et al. Regulation of renal tubular glucose reabsorption by Akt2/PKBβ. Am J Physiol Renal Physiol. 2010;298(5):F1113–7.
- Yang W, Nurbaeva MK, Schmid E, et al. Akt2- and ETS1-dependent IP3 receptor 2 expression in dendritic cell migration. Cell Physiol Biochem. 2014;33(1):222–236.
- Bhandaru M, Yang W, Rotte A, et al. Regulation of Na+/H + exchanger in dendritic cells by Akt2. Pflugers Arch. 2012;463(2):355–363.
- Gao YX, He WT, Pan LF, et al. Downregulation of Akt2 attenuates ER stress-induced cytotoxicity through JNK-Wnt pathway in cardiomyocytes. Bioorg Med Chem Lett. 2018;28(3):394–399.
- Cui Y, Lin J, Zuo J, et al. AKT2-knockdown suppressed viability with enhanced apoptosis, and attenuated chemoresistance to temozolomide of human glioblastoma cells in vitro and in vivo. Onco Targets Ther. 2015;8:1681–1690.
- Huang Q, Lan F, Zheng Z, et al. Akt2 kinase suppresses glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-mediated apoptosis in ovarian cancer cells via phosphorylating GAPDH at threonine 237 and decreasing its nuclear translocation. J Biol Chem. 2011;286(49):42211–42220.
- Jain SS, Luiken JJ, Snook LA, et al. Fatty acid transport and transporters in muscle are critically regulated by Akt2. FEBS Lett. 2015;589(19PartB):2769–2775.
- Kim HG, Yang WS, Hong YH, et al. Anti-inflammatory functions of the CDC25 phosphatase inhibitor BN82002 via targeting AKT2. Biochem Pharmacol. 2019;164:216–227.
- Xuan NT, Wang X, Nishanth G, et al. A20 expression in dendritic cells protects mice from LPS-induced mortality. Eur J Immunol. 2015;45(3):818–828.
- Wang X, Deckert M, Xuan NT, et al. Astrocytic A20 ameliorates experimental autoimmune encephalomyelitis by inhibiting NF-kappaB- and STAT1-dependent chemokine production in astrocytes. Acta Neuropathol. 2013;126(5):711–724.
- Xuan NT, Wang X, Nishanth G, et al. A20 expression in dendritic cells protects mice from LPS-induced mortality. Eur J Immunol. 2015;45:818–828.
- Lee EG, Boone DL, Chai S, et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science. 2000;289(5488):2350–2354.
- Wang Y, Park NY, Jang Y, et al. Vitamin E gamma-tocotrienol inhibits cytokine-stimulated NF-kappaB activation by induction of anti-inflammatory A20 via stress adaptive response due to modulation of sphingolipids. J Immunol. 2015;195(1):126–133.
- Xu H, Wang L, Zheng P, et al. Elevated serum A20 is associated with severity of chronic hepatitis B and A20 inhibits NF-kappaB-mediated inflammatory response. Oncotarget. 2017;8(24):38914–38926.
- Sun L, Zou LX, Han YC, et al. A20 overexpression exerts protective effects on podocyte injury in lupus nephritis by downregulating UCH-L1. J Cell Physiol. 2019;234(9):16191.
- Zhou Q, Wang H, Schwartz DM, et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet. 2016;48(1):67–73.
- De Wilde K, Martens A, Lambrecht S, et al. A20 inhibition of STAT1 expression in myeloid cells: a novel endogenous regulatory mechanism preventing development of enthesitis. Ann Rheum Dis. 2017;76(3):585–592.
- Johansson P, Bergmann A, Rahmann S, et al. Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia. Int J Cancer. 2016;138(1):121–124.
- Zhang F, Yang L, Li Y. The role of A20 in the pathogenesis of lymphocytic malignancy. Cancer Cell Int. 2012;12(1):44.
- Wang X, Ma C, Zong Z, et al. A20 inhibits the motility of HCC cells induced by TNF-α. Oncotarget. 2016;7(12):14742–14754.
- Opipari AW, Jr., Hu HM, Yabkowitz R, et al. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem. 1992;267(18):12424–12427.
- Daniel S, Patel VI, Shrikhande GV, et al. The universal NF-kappaB inhibitor a20 protects from transplant vasculopathy by differentially affecting apoptosis in endothelial and smooth muscle cells. Transplant Proc. 2006;38(10):3225–3227.
- Hou CL, Huang Q, Wei Y, et al. Protein transduction domain-hA20 fusion protein protects endothelial cells against high glucose-induced injury. Genet Mol Res. 2012;11(3):1899–1908.
- Cho H, Mu J, Kim JK, et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science. 2001;292(5522):1728–1731.
- Kim YA, Kim HY, Oh YJ, et al. Polychlorinated biphenyl 138 exposure-mediated lipid droplet enlargement endows adipocytes with resistance to TNF-alpha-induced cell death. Toxicol Lett. 2018;292:55–62.
- Simpson J, Miles K, Trub M, et al. Plasmacytoid dendritic cells respond directly to apoptotic cells by secreting immune regulatory IL-10 or IFN-α. Front Immunol. 2016;7:590.
- Shrikhande GV, Scali ST, da Silva CG, et al. O-glycosylation regulates ubiquitination and degradation of the anti-inflammatory protein A20 to accelerate atherosclerosis in diabetic ApoE-null mice. PLoS One. 2010;5(12):e14240.
- Wang L, Xu X, Huo N, et al. A combination of insulin and ubiquitin A20 promotes osteocalcin expression in adipose-derived stem cells. Biochem Cell Biol. 2013;91(6):513–518.
- Gonzalez E, McGraw TE. The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle. 2009;8(16):2502–2508.
- Stambolic V, Woodgett JR. Functional distinctions of protein kinase B/Akt isoforms defined by their influence on cell migration. Trends Cell Biol. 2006;16(9):461–466.
- Xuan NT, Shumilina E, Matzner N, et al. Ca2+-dependent functions in peptidoglycan-stimulated mouse dendritic cells. Cell Physiol Biochem. 2009;24(3-4):167–176.
- Shumilina E, Zahir N, Xuan NT, et al. Phosphoinositide 3-kinase dependent regulation of Kv channels in dendritic cells. Cell Physiol Biochem. 2007;20(6):801–808.
- O'Donnell JS, Massi D, Teng MWL, et al. PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux. Semin Cancer Biol. 2018;48:91–103.